Loading clinical trials...
Loading clinical trials...
The purpose of the study is to evaluate the safety and tolerability of fluvastatin 80 mg in a Chinese population. This study is not recruiting patients in the US.
Age
18 - 80 years
Sex
ALL
Healthy Volunteers
No
Novartis
Shanghai, China
Start Date
June 1, 2005
Primary Completion Date
April 1, 2006
Completion Date
April 1, 2006
Last Updated
February 23, 2017
325
ACTUAL participants
Fluvastatin
DRUG
Lead Sponsor
Novartis
NCT07058077
NCT06555120
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06287177